Jul. 28, 2015, 3:42 AM
- Hikma Pharmaceuticals (OTCPK:HKMPY) will buy Boehringer Ingelheim GmbH’s Roxane business for $2.65B to become the sixth-largest supplier of generic medicines in the U.S.
- Hikma, which will pay $1.18B in cash and issue 40M new shares to Boehringer, has also agreed to make milestone cash payments of up to $125M.
Jun. 30, 2015, 10:08 AM| Jun. 30, 2015, 10:08 AM | 3 Comments